This prompted us to next investigate if the addition of anti-PD-1 ICB or anti-CTLA-4 ICB might attenuate the surgery-mediated suppression in lymphocyte killing of OE33 P and OE33 R tumour cells (Figure 6A). This evidence concerns the gene CTLA4 and neoplasm.